Health Boards
›
Psoriasis In The News
Methorexate drug survival rate is low in psoriasis patients
|
Methorexate drug survival rate is low in psoriasis patients
|
Fri-18-08-2017, 21:06 PM
Most people can get 2 - 4 years on the drug. At that point, the risk of liver damage increases and typically discontinued by the doctor. That is why when MTX is used as a contaminant with a biologics it typically give at lower doe (10) in an attempt to increase long term use.
|
|
« Next Oldest | Next Newest »
|
| Possibly Related Threads… | |||||
| Thread | Author | Replies | Views | Last Post | |
|
CAL101 phase 1 on patients with psoriasis | Fred | 6 | 842 |
Fri-25-10-2024, 15:51 PM Last Post: Fred |
|
|
High level of arthritis in psoriasis patients | Fred | 1 | 621 |
Wed-21-08-2024, 13:05 PM Last Post: Caroline |
|
|
Effectiveness of Tremfya in patients with facial and/or genital psoriasis | Fred | 0 | 845 |
Fri-28-06-2024, 13:10 PM Last Post: Fred |
|
|
IL 17 & 23 with elderly psoriasis patients | Fred | 0 | 778 |
Thu-13-06-2024, 13:56 PM Last Post: Fred |
|
|
Taiwan study on infections in psoriasis patients | Fred | 4 | 3,164 |
Sat-26-08-2023, 11:15 AM Last Post: Fred |
